期刊论文详细信息
Journal of Leukocyte Biology
Differential effects of selective HDAC inhibitors on macrophage inflammatory responses to the Toll-like receptor 4 agonist LPS
Kate Schroder2  Maria A. Halili1  Melanie R. Andrews1  Katharine M. Irvine1  Larisa I. Labzin1  David A. Hume4  Chun Cao3  Erica Lovelace1  Giang T. Le1  Robert C. Reid1  David P. Fairlie1  Matthew J. Sweet1  Patrick Matthias3  Gabriele Matthias3 
[1] The University of Queensland, Institute for Molecular Bioscience, Brisbane, Queensland, Australia; The University of Queensland, Institute for Molecular Bioscience, Brisbane, Queensland, Australia; The University of Queensland, Institute for Molecular Bioscience, Brisbane, Queensland, Australia;Department of Biochemistry, University of Lausanne, Epalinges, Switzerland; Department of Biochemistry, University of Lausanne, Epalinges, Switzerland; Department of Biochemistry, University of Lausanne, Epalinges, Switzerland;;Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland; and Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland; and Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland; and;The Roslin Institute and Royal (Dick) School of Veterinary Studies, University of Edinburgh, Scotland, United Kingdom The Roslin Institute and Royal (Dick) School of Veterinary Studies, University of Edinburgh, Scotland, United Kingdom The Roslin Institute and Royal (Dick) School of Veterinary Studies, University of Edinburgh, Scotland, United Kingdom
关键词: HDAC6;    histone deacetylase;    inflammation;    sepsis;    SAHA;    TLR;   
DOI  :  10.1189/jlb.0509363
学科分类:生理学
来源: Federation of American Societies for Experimental Biology
PDF
【 摘 要 】

Broad-spectrum inhibitors of HDACs are therapeutic in many inflammatory disease models but exacerbated disease in a mouse model of atherosclerosis. HDAC inhibitors have anti- and proinflammatory effects on macrophages in vitro. We report here that several broad-spectrum HDAC inhibitors, including TSA and SAHA, suppressed the LPS-induced mRNA expression of the proinflammatory mediators Edn-1, Ccl-7/MCP-3, and Il-12p40 but amplified the expression of the proatherogenic factors Cox-2 and Pai-1/serpine1 in primary mouse BMM. Similar effects were also apparent in LPS-stimulated TEPM and HMDM. The pro- and anti-inflammatory effects of TSA were separable over a concentration range, implying that individual HDACs have differential effects on macrophage inflammatory responses. The HDAC1-selective inhibitor, MS-275, retained proinflammatory effects (amplification of LPS-induced expression of Cox-2 and Pai-1 in BMM) but suppressed only some inflammatory responses. In contrast, 17a (a reportedly HDAC6-selective inhibitor) retained anti-inflammatory but not proinflammatory properties. Despite this, HDAC6−/− macrophages showed normal LPS-induced expression of HDAC-dependent inflammatory genes, arguing that the anti-inflammatory effects of 17a are not a result of inhibition of HDAC6 alone. Thus, 17a provides a tool to identify individual HDACs with proinflammatory properties.

【 授权许可】

Unknown   

【 预 览 】
附件列表
Files Size Format View
RO201912010182767ZK.pdf 43KB PDF download
  文献评价指标  
  下载次数:19次 浏览次数:7次